New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
09:18 EDTNYX, DFS, BBBY, CAG, JBL, RAD, ORCL, ELOQ, VVUS, MDRX, ICE, FOLDOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Rite Aid (RAD), up 17.3%... Jabil Circuit (JBL), up 5.4%... ConAgra (CAG), up 3.1%... ALSO HIGHER: NYSE Euronext (NYX), up 40.2% after acquisition by IntercontinentalExchange (ICE) for $33.12 per share in case and stock... Eloqua (ELOQ), up 30% after agreeing to be bought by Oracle (ORCL) for $23.50... VIVUS (VVUS), up 7.9% after Express Scripts (ESRX) adds Qsymia to formulary, takeover speculation fueled by Daily Mail report... LOWER AFTER EARNINGS: Bed Bath & Beyond (BBBY), down 5.8%... Discover (DFS), down 2.2%... ALSO LOWER: Amicus Therapeutics (FOLD), down 43.5% after drug doesn't show statistical benefit in study... Allscripts (MDRX), down 15.9% after evaluation of strategic alternatives ends without sale, CEO steps down.
News For NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD From The Last 14 Days
Check below for free stories on NYX;ICE;MDRX;VVUS;ELOQ;ORCL;RAD;JBL;CAG;BBBY;DFS;FOLD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 30, 2014
09:25 EDTDFSDiscover still looks attractive, Barron's says
Discover shares have climbed 20% since November and should continue higher with an increase in interest rates, Barron's contends in a follow up article. The stock could provide a double-digit return over the next year, especially if rates rise in 2015, the paper adds. Reference Link
August 29, 2014
18:19 EDTORCLOracle bid to restore $1.3B SAP verdict denied, Reuters reports
Subscribe for More Information
14:16 EDTORCLEuropean Commission approves Oracle acquisition of MICROS
Subscribe for More Information
11:40 EDTORCLVeeva soars following beat and raise quarter
Subscribe for More Information
August 28, 2014
06:57 EDTFOLDAmicus Therapeutics volatility decreases on sharp rally
Amicus Therapeutics September call option implied volatility is at 86, October is at 90, January is at 89, April is at 88; compared to its 26-week average of 109 according to Track Data, suggesting decreasing price risk.
August 27, 2014
09:53 EDTORCLOn The Fly: Analyst Initiation Summary
Bristol-Myers (BMY) initiated with a Hold at Deutsche Bank... ASML (ASML) initiated with a Hold at Stifel... Akamai (AKAM) initiated with an Outperform at RW Baird... Concur (CNQR) initiated with a Neutral at DA Davidson... CyrusOne (CONE) initiated with a Neutral at Citigroup... Eli Lilly (LLY) initiated with a Buy at Deutsche Bank... Garmin (GRMN) initiated with a Neutral at RW Baird... Merck (MRK) initiated with a Hold at Deutsche Bank... NetSuite (N) initiated with a Buy at DA Davidson... Oracle (ORCL) initiated with a Neutral at DA Davidson... Oxford Industries (OXM) initiated with a Buy at Wunderlich... Pfizer (PFE) initiated with a Buy at Deutsche Bank... ServiceNow (NOW) initiated with a Buy at DA Davidson... Workday (WDAY) initiated with a Neutral at DA Davidson... MannKind (MNKD) initiated with a Buy at Jefferies... STMicroelectronics (STM) initiated with an Underperform at Credit Suisse... Kirkland's (KIRK) initiated with an Outperform at Barrington.
August 26, 2014
17:33 EDTORCLOracle initiated with a Neutral at DA Davidson
Subscribe for More Information
11:23 EDTFOLDTRW September volatility elevated
Subscribe for More Information
August 25, 2014
11:11 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD ITMN AEO DKS WUBA URBN SPLS YOKU GME
07:03 EDTVVUSVIVUS acquires patents from Janssen Pharmaceuticals
VIVUS (VVUS) announced the acquisition of a group of patents from Janssen Pharmaceuticals (JNJ) covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. Janssen has agreed to dismiss the lawsuit it brought against VIVUS on August 22, 2014 in the U.S. District Court for the District of Delaware. VIVUS will pay a one-time upfront fee and a royalty to Janssen on Qsymia product sales for an assignment of these topiramate-related patents owned by Janssen. VIVUS has an option to buy out the royalty for a predetermined amount.
06:11 EDTFOLDStocks with implied volatility movement; FOLD GILD
Stocks with implied volatility movement; Amicus Therapeutics (FOLD) 87, Gilead (GILD) 25 according to iVolatility.
August 24, 2014
21:53 EDTRADNational Association of Chain Drug Stores to hold an expo
2014 NACDS Total Store Expo to be held in Boston on August 23-25.
August 22, 2014
13:49 EDTORCLOregon sues Oracle over health exchange website
Subscribe for More Information
11:26 EDTORCLSalesforce.com rallies following beat and raise quarter
Subscribe for More Information
10:06 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD GME YOKU SPLS DKS WUBA ARWR ACHN
August 21, 2014
10:22 EDTFOLDOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD VHC ACHN JCP WB JD YPF
August 20, 2014
11:42 EDTFOLDOptions with decreasing implied volatility
Subscribe for More Information
11:09 EDTFOLDHigh option volume stocks
Subscribe for More Information
10:31 EDTFOLDAmicus price target raised its price target to $14 from $9 at Cowen
Subscribe for More Information
09:36 EDTFOLDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use